logo-loader
British American Tobacco PLC

BAT to make around £436mln provision after Quebec court upheld 2015 decision against Canadian unit

As part of the 2015 decision, ITCAN was required to place C$758mln (approximately £436mln) in escrow and BAT said its board have determined that that asset's recoverability is "less than virtually certain”

Smoker
BAT said that there will be no impact from the charge to adjusted net debt to adjusted underlying earnings (EBITDA) ratio or to 2019 cash flow

British American Tobacco plc (LON:BATS) will make a provision of around £436mln in its 2019 accounts after a Quebec appeal court last week upheld a 2015 decision that awarded smokers in the Canadian province around C$15bn, about £8.5bn against its  Imperial Tobacco Canada Ltd. (ITCAN) and two other firms.

In a statement on Tuesday, the FTSE 100-listed tobacco firm pointed out that, as part of the 2015 decision, ITCAN was required to place C$758mln (approximately £436mln) in escrow and said its board have determined that that asset's recoverability “is, under IFRS, less than virtually certain.” 

It said that there will be no impact from the charge to adjusted net debt to adjusted underlying earnings (EBITDA) ratio or to 2019 cash flow.

READ: BAT “extremely disappointed” Quebec class action lawsuit judgment against Canadian subsidiary not overturned

In a statement on Monday, a spokesperson for BAT had said: “We are still of the view that this decision is wrong - ignoring the reality that both adult consumers and government have known about the risk associated with smoking for decades. As a result, we believe it should be overturned.”

The spokesperson added: "Imperial Tobacco Canada Ltd. needs to review the court's decision in more detail and will decide on next steps over the coming days and weeks. Given the significance of the judgment, they have said that they fully intend to appeal the decision to the Supreme Court of Canada."

Quick facts: British American Tobacco PLC

Price: £29.95

Market: LSE
Market Cap: £68.49 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Open Orphan PLC targeting 'value creation and rapid scale-up'

Proactive Research analyst Emma Ulker discusses the opportunity with Open Orphan PLC (LON:ORPH). She says the firm's targeting value creation and rapid scale-up via acquisitions in the orphan and rare drugs market - a space which is growing at around 11% a year. Ulker adds they're looking...

19 hours, 15 minutes ago

RNS

Director/PDMR Shareholding

4 days, 21 hours ago

Director/PDMR Shareholding

5 days, 1 hour ago

Director/PDMR Shareholding

5 days, 1 hour ago

Director/PDMR Shareholding

5 days, 1 hour ago

Director/PDMR Shareholding

1 week, 1 day ago

Director/PDMR Shareholding

1 week, 1 day ago

Director/PDMR Shareholding

1 week, 1 day ago

Director/PDMR Shareholding

1 week, 1 day ago

2 min read